These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009]. Kwiecińska-Piróg J; Bogiel T; Gospodarek E Przegl Epidemiol; 2010; 64(3):395-8. PubMed ID: 20976952 [TBL] [Abstract][Full Text] [Related]
5. Occurrence of extended-spectrum (beta)-lactamases and plasmid-mediated AmpC (beta)-lactamases among Korean isolates of Proteus mirabilis. Park YJ; Lee S; Kim YR; Oh EJ; Woo GJ; Lee K J Antimicrob Chemother; 2006 Jan; 57(1):156-8. PubMed ID: 16284101 [No Abstract] [Full Text] [Related]
6. Molecular epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Proteus mirabilis isolates in Taiwan. Huang CW; Chien JH; Peng RY; Tsai DJ; Li MH; Lee HM; Lin CF; Lee MC; Liao CT Int J Antimicrob Agents; 2015 Jan; 45(1):84-5. PubMed ID: 25446905 [No Abstract] [Full Text] [Related]
7. First description of DHA-1 ampCbeta-lactamase in Proteus mirabilis. Bidet P; Verdet C; Gautier V; Bingen E; Arlet G Clin Microbiol Infect; 2005 Jul; 11(7):591-2. PubMed ID: 15966982 [TBL] [Abstract][Full Text] [Related]
10. Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene. Vourli S; Tsorlini H; Katsifa H; Polemis M; Tzouvelekis LS; Kontodimou A; Vatopoulos AC Clin Microbiol Infect; 2006 Jul; 12(7):691-4. PubMed ID: 16774572 [TBL] [Abstract][Full Text] [Related]
11. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management. Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415 [TBL] [Abstract][Full Text] [Related]
12. Differences in biofilm formation and aggregative adherence between beta-lactam susceptible and beta-lactamases producing P. mirabilis clinical isolates. Nucleo E; Fugazza G; Migliavacca R; Spalla M; Comelli M; Pagani L; Debiaggi M New Microbiol; 2010 Jan; 33(1):37-45. PubMed ID: 20402412 [TBL] [Abstract][Full Text] [Related]
14. Prolonged bacteraemia caused by VIM-1 metallo-beta-lactamase-producing Proteus mirabilis: first report from Italy. Falcone M; Perilli M; Mezzatesta ML; Mancini C; Amicosante G; Stefani S; Venditti M Clin Microbiol Infect; 2010 Feb; 16(2):179-81. PubMed ID: 19624511 [TBL] [Abstract][Full Text] [Related]
15. Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report. Savini V; Catavitello C; Talia M; Di Berardino F; Manna A; Balbinot A; Febbo F; Carlino D; Fioritoni F; Di Bonaventura G; D'Antonio D Int J Low Extrem Wounds; 2008 Jun; 7(2):99-101. PubMed ID: 18483010 [TBL] [Abstract][Full Text] [Related]
16. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients. Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340 [TBL] [Abstract][Full Text] [Related]
17. Molecular diversity of Proteus mirabilis isolates producing extended-spectrum beta-lactamases in a French university hospital. Biendo M; Thomas D; Laurans G; Hamdad-Daoudi F; Canarelli B; Rousseau F; Castelain S; Eb F Clin Microbiol Infect; 2005 May; 11(5):395-401. PubMed ID: 15819867 [TBL] [Abstract][Full Text] [Related]
18. F2:A-:B- plasmid carrying the extended-spectrum β-lactamase bla(CTX-M-55/57) gene in Proteus mirabilis isolated from a primate. Dahmen S; Madec JY; Haenni M Int J Antimicrob Agents; 2013 Jun; 41(6):594-5. PubMed ID: 23507413 [No Abstract] [Full Text] [Related]
19. High prevalence and molecular characterization of extended-spectrum β-lactamase-producing Proteus mirabilis strains in southern Croatia. Tonkić M; Mohar B; Šiško-Kraljević K; Meško-Meglič K; Goić-Barišić I; Novak A; Kovačić A; Punda-Polić V J Med Microbiol; 2010 Oct; 59(Pt 10):1185-1190. PubMed ID: 20558587 [TBL] [Abstract][Full Text] [Related]